SARAH LUCAS: Open Payments
NPI 1619273885 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 16 payments from 6 companies in 2025. Trend: 2023 $577 · 2024 $273 · 2025 $447
Food & beverage: $272Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $188 |
| Exeltis, USA Inc. | 6 | $108 |
| Astellas Pharma US Inc | 3 | $60 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| UCB, Inc. | 2 | $36 |
| Janssen Biotech, Inc. | 1 | $18 |
Products named: PROLIA, SLYND, Veozah, Bimzelx, MYFEMBREE, TREMFYA, GEMTESA, EVENITY.
Industry payments across KY — which companies pay providers there.
